vs
Side-by-side financial comparison of T Stamp Inc (IDAI) and PLUS THERAPEUTICS, INC. (PSTV). Click either name above to swap in a different company.
PLUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($1.4M vs $908.9K, roughly 1.5× T Stamp Inc). T Stamp Inc runs the higher net margin — -279.9% vs -417.9%, a 138.0% gap on every dollar of revenue. On growth, PLUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (-3.2% vs -39.3%). T Stamp Inc produced more free cash flow last quarter ($2.0M vs $-6.3M). Over the past eight quarters, T Stamp Inc's revenue compounded faster (25.9% CAGR vs -9.7%).
T Stamp Inc, trading under ticker IDAI, develops AI-powered identity verification, trust scoring, and fraud prevention solutions. It serves clients across fintech, healthcare, and e-commerce segments, primarily operating in North America to help organizations securely authenticate user identities and mitigate fraud risks.
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system (CNS) cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecu...
IDAI vs PSTV — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $908.9K | $1.4M |
| Net Profit | $-2.5M | $-5.7M |
| Gross Margin | — | — |
| Operating Margin | -224.9% | -420.0% |
| Net Margin | -279.9% | -417.9% |
| Revenue YoY | -39.3% | -3.2% |
| Net Profit YoY | 57.7% | -46.4% |
| EPS (diluted) | $-0.37 | $0.95 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $908.9K | $1.4M | ||
| Q3 25 | $872.5K | $1.4M | ||
| Q2 25 | $812.7K | $1.4M | ||
| Q1 25 | $545.5K | $1.1M | ||
| Q4 24 | $1.5M | $1.4M | ||
| Q3 24 | $511.1K | $1.5M | ||
| Q2 24 | $500.4K | $1.3M | ||
| Q1 24 | $573.7K | $1.7M |
| Q4 25 | $-2.5M | $-5.7M | ||
| Q3 25 | $-1.9M | $-4.4M | ||
| Q2 25 | $-1.7M | $5.2M | ||
| Q1 25 | $-2.2M | $-17.4M | ||
| Q4 24 | $-6.0M | $-3.9M | ||
| Q3 24 | $-1.3M | $-2.9M | ||
| Q2 24 | $-2.6M | $-2.9M | ||
| Q1 24 | $-2.7M | $-3.3M |
| Q4 25 | -224.9% | -420.0% | ||
| Q3 25 | -203.0% | -320.8% | ||
| Q2 25 | -207.0% | -110.6% | ||
| Q1 25 | -396.5% | -333.9% | ||
| Q4 24 | -81.2% | -276.2% | ||
| Q3 24 | -523.7% | -260.9% | ||
| Q2 24 | -524.7% | -289.1% | ||
| Q1 24 | -496.7% | -196.7% |
| Q4 25 | -279.9% | -417.9% | ||
| Q3 25 | -219.1% | -316.6% | ||
| Q2 25 | -210.7% | 370.6% | ||
| Q1 25 | -395.5% | -1643.2% | ||
| Q4 24 | -401.5% | -276.4% | ||
| Q3 24 | -245.7% | -197.4% | ||
| Q2 24 | -519.3% | -229.9% | ||
| Q1 24 | -466.9% | -194.5% |
| Q4 25 | $-0.37 | $0.95 | ||
| Q3 25 | $-0.72 | $-0.04 | ||
| Q2 25 | $-0.69 | $-0.01 | ||
| Q1 25 | $-0.89 | $-1.19 | ||
| Q4 24 | $-3.14 | $-0.51 | ||
| Q3 24 | $-1.06 | $-0.37 | ||
| Q2 24 | $-3.19 | $-0.71 | ||
| Q1 24 | $-3.97 | $-0.75 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $6.0M | $8.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $8.7M | $4.0M |
| Total Assets | $11.2M | $16.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.0M | $8.6M | ||
| Q3 25 | $5.4M | $16.6M | ||
| Q2 25 | $292.1K | $6.9M | ||
| Q1 25 | $1.1M | $9.9M | ||
| Q4 24 | $2.8M | $3.6M | ||
| Q3 24 | $598.0K | $4.8M | ||
| Q2 24 | $659.5K | $8.4M | ||
| Q1 24 | $816.7K | $3.2M |
| Q4 25 | $8.7M | $4.0M | ||
| Q3 25 | $6.1M | $5.1M | ||
| Q2 25 | $2.4M | $3.0M | ||
| Q1 25 | $4.1M | $-23.6M | ||
| Q4 24 | $3.0M | $-8.9M | ||
| Q3 24 | $5.4M | $-5.2M | ||
| Q2 24 | $750.4K | $-7.6M | ||
| Q1 24 | $1.4M | $-4.8M |
| Q4 25 | $11.2M | $16.3M | ||
| Q3 25 | $11.2M | $18.7M | ||
| Q2 25 | $5.7M | $10.3M | ||
| Q1 25 | $6.6M | $12.1M | ||
| Q4 24 | $8.6M | $6.6M | ||
| Q3 24 | $10.6M | $7.0M | ||
| Q2 24 | $5.2M | $11.2M | ||
| Q1 24 | $5.6M | $5.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.0M | $-6.3M |
| Free Cash FlowOCF − Capex | $2.0M | $-6.3M |
| FCF MarginFCF / Revenue | 215.4% | -459.9% |
| Capex IntensityCapex / Revenue | 0.8% | 2.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-5.7M | $-20.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.0M | $-6.3M | ||
| Q3 25 | $-4.0M | $-2.5M | ||
| Q2 25 | $-2.1M | $-5.8M | ||
| Q1 25 | $-1.5M | $-6.2M | ||
| Q4 24 | $-2.7M | $-1.2M | ||
| Q3 24 | $-2.4M | $-3.7M | ||
| Q2 24 | $-1.6M | $-1.1M | ||
| Q1 24 | $-2.2M | $-4.5M |
| Q4 25 | $2.0M | $-6.3M | ||
| Q3 25 | $-4.0M | $-2.6M | ||
| Q2 25 | $-2.1M | $-5.8M | ||
| Q1 25 | $-1.6M | $-6.2M | ||
| Q4 24 | $-2.7M | $-1.2M | ||
| Q3 24 | $-2.4M | $-3.7M | ||
| Q2 24 | $-1.6M | $-1.2M | ||
| Q1 24 | $-2.2M | $-4.6M |
| Q4 25 | 215.4% | -459.9% | ||
| Q3 25 | -459.6% | -184.3% | ||
| Q2 25 | -258.6% | -417.6% | ||
| Q1 25 | -289.2% | -583.1% | ||
| Q4 24 | -182.9% | -86.5% | ||
| Q3 24 | -475.4% | -253.7% | ||
| Q2 24 | -320.9% | -96.2% | ||
| Q1 24 | -376.6% | -271.5% |
| Q4 25 | 0.8% | 2.2% | ||
| Q3 25 | 0.0% | 1.9% | ||
| Q2 25 | 0.2% | 0.5% | ||
| Q1 25 | 6.8% | 0.3% | ||
| Q4 24 | 0.1% | 0.8% | ||
| Q3 24 | 0.7% | 1.0% | ||
| Q2 24 | 1.3% | 6.3% | ||
| Q1 24 | 0.5% | 2.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -1.13× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
